Drug intelligence / Profile preview

COYA 206

Development stage: Preclinical
Lead developer: Coya Therapeutics
Modality: Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Recombinant Proteins and Enzymes
Administration: Unknown

Overview

COYA 206 is an investigational immunomodulatory therapy consisting of antigen-directed regulatory T cell (Treg)-derived exosomes designed to modulate immune responses. It is being developed by Coya Therapeutics for use in neurodegenerative and other inflammation-related diseases. COYA 206 represents a new molecular entity in the therapeutic pipeline and leverages exosome technology to exert immunoregulatory effects, with Treg-derived exosomes intended to restore immune homeostasis by modulating inflammation. The drug leverages recent advances in exosome-polymer hybrid technology with intellectual property originating at Carnegie Mellon University. Its principal mechanism of action is immunomodulation, aiming to restore anti-inflammatory functions and mitigate pathological inflammation.

Brand names: COYA 206COYA206COYA-206
Other names: COYA 206COYA206COYA-206

Beyond the preview

Go deeper on COYA 206.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on COYA 206.

Explore the full profile